EMAPARTNER stock news
This page provides real-time market news, earnings updates, and company announcements related to Ema Partners India Limited (EMAPARTNER).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-20 12:59 IST
Pre-market: Nasdaq futures up 0.45%, Palantir up nearly 12%
新浪财经2026-02-03 13:45:44
Here’s why NVIDIA stock price could be at risk of a crash to $150
CryptoNewsNet2026-02-04 20:45:35
MicroStrategy Falls 22% as Bitcoin Losses Mount — Why a Rebound Case Still Exists
BeInCrypto2026-02-05 15:36:16
Strategy (MSTR) Stock Jumps 33% on Revenue and Bitcoin Boost — Can the Rally Hold?
BeInCrypto2026-02-10 12:45:15
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-12 11:33:45
BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Finviz2026-02-12 12:36:09
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
Finviz2026-02-12 13:33:05
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Finviz2026-02-12 13:36:12
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
Finviz2026-02-13 11:21:20
Crypto Trader To Tesla Bulls: 'Give Me One Reason Why TSLA Is Worth $1.3 Trillion'
Finviz2026-02-13 17:15:36
Cytokinetics Announces European Commission Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Finviz2026-02-17 12:33:42
Cellectar Biosciences Expands Global Intellectual Property Estate
Finviz2026-02-17 13:09:11
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
Finviz2026-02-17 13:36:43
OS Therapies Discloses 2026 Timeline For Lead Drug Regulatory Filings
Finviz2026-02-17 14:03:14
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Why Is the US Stock Market Down Today?
CryptoNewsNet2026-02-17 20:21:43
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-18 12:03:22
NervGen Pharma to Participate at Upcoming Investor Conferences
Finviz2026-02-18 12:33:42
Robinhood Launches $1B Fund To Give Retail Investors Access To Space X, Stripe
Finviz2026-02-18 13:03:46
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Finviz2026-02-18 13:24:36
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer
Finviz2026-02-18 15:21:12
Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan
Finviz2026-02-19 00:39:37
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
Finviz2026-02-19 16:33:05
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-02-12 11:33:45
BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Finviz2026-02-12 12:36:09
Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update
Finviz2026-02-12 13:33:05
MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides
Finviz2026-02-12 13:36:12
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
Finviz2026-02-13 11:21:20
Crypto Trader To Tesla Bulls: 'Give Me One Reason Why TSLA Is Worth $1.3 Trillion'
Finviz2026-02-13 17:15:36
Cytokinetics Announces European Commission Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
Finviz2026-02-17 12:33:42
Cellectar Biosciences Expands Global Intellectual Property Estate
Finviz2026-02-17 13:09:11
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
Finviz2026-02-17 13:36:43
OS Therapies Discloses 2026 Timeline For Lead Drug Regulatory Filings
Finviz2026-02-17 14:03:14
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Cosmos Health Showcases Expanding Brand Portfolio at World Health Expo Dubai 2026
Finviz2026-02-17 16:27:37
Why Is the US Stock Market Down Today?
CryptoNewsNet2026-02-17 20:21:43
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-02-18 12:03:22
NervGen Pharma to Participate at Upcoming Investor Conferences
Finviz2026-02-18 12:33:42
Robinhood Launches $1B Fund To Give Retail Investors Access To Space X, Stripe
Finviz2026-02-18 13:03:46
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
Finviz2026-02-18 13:24:36
Cosmos Health Announces Growing Momentum for C-Scrub in the United Kingdom; Now Available at Tesco, the UK's Largest Retailer
Finviz2026-02-18 15:21:12
Bullish Analyst Opinion on Dyne (DYNE) Follows Rare Disease Drug Progress in Japan
Finviz2026-02-19 00:39:37
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
Finviz2026-02-19 16:33:05
EMAPARTNER stock price change
On the last trading day, EMAPARTNER stock closed at 86.60 INR, with a price change of -5.36% for the day.
Trade stock futuresEMAPARTNER stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more